- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Walgreens Boots Alliance Inc (WBA)
Walgreens Boots Alliance Inc stock price live, this page displays NASDAQ WBA stock exchange data. View the WBA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Walgreens Boots Alliance Inc real time stock price chart below.
What Is the Walgreens Boots Alliance Inc Stock Price Today?
The Walgreens Boots Alliance Inc stock price today is 96.68.
What Is the Stock Symbol for Walgreens Boots Alliance Inc?
The stock symbol for Walgreens Boots Alliance Inc is ""WBA.""
What Stock Exchange Does Walgreens Boots Alliance Inc Trade On?
Walgreens Boots Alliance Inc is listed and trades on the NASDAQ stock exchange.
Is Walgreens Boots Alliance Inc a Good Stock to Buy?
Determining whether Walgreens Boots Alliance Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WBA quote. (ISIN: US9314271084)
What Is the Walgreens Boots Alliance Inc Stock Price Today?
The Walgreens Boots Alliance Inc stock price today is 96.68.
What Is the Stock Symbol for Walgreens Boots Alliance Inc?
The stock symbol for Walgreens Boots Alliance Inc is ""WBA.""
What Stock Exchange Does Walgreens Boots Alliance Inc Trade On?
Walgreens Boots Alliance Inc is listed and trades on the NASDAQ stock exchange.
Is Walgreens Boots Alliance Inc a Good Stock to Buy?
Determining whether Walgreens Boots Alliance Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WBA quote. (ISIN: US9314271084)
96.68
0.00(0.00%)
Closed·
Day's Range
96.29
97.30
52 wk Range
0.00
97.30
Showing Walgreens Boots historical data. For real-time data please try another search
Day's Range
96.2997.30
52 wk Range
0.0097.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Walgreens Boots Alliance Inc Company Profile
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. The company operates in three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in the operation of retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offer health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers the sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was formerly known as Walgreen Co. and changed its name to Walgreens Boots Alliance, Inc. in December 2014. Walgreens Boots Alliance, Inc. was founded in 1909 and is based in Deerfield, Illinois.
Walgreens Boots Alliance Inc SWOT Analysis
Strategic Overhaul | Walgreens Boots Alliance embarks on a transformative journey, evaluating closure of up to 25% of stores and appointing new leadership to revitalize its healthcare strategy |
Financial Headwinds | Explore WBA's fiscal challenges, including downward EPS revisions, margin pressures, and a substantial $33.8 billion debt burden impacting its financial health |
Healthcare Ambitions | Delve into WBA's renewed focus on its US Healthcare segment, particularly the promising clinical trials business, as a potential avenue for future growth |
Analyst Perspectives | Discover varied analyst views on WBA's future, with price targets ranging from $7 to $21, reflecting the company's complex strategic shifts and market uncertainties |
Walgreens Boots Alliance Inc Earnings Call Summary for Q4/2024
- Q4 adjusted EPS down 41% to $0.39; full-year EPS fell 28% to $2.88. Net debt reduced by $1.9B in fiscal 2024.
- WBA to close 1,200 stores over three years as part of optimization program. Fiscal 2025 EPS guidance set at $1.40-$1.80.
- Company targets $1B+ in cost savings, plans $500M working capital optimization in fiscal 2025. U.S. Healthcare EBITDA to improve by $250M.
- CEO emphasizes early stages of turnaround, focus on operational priorities. Exploring monetization options for VillageMD unit.
- Challenges include price-sensitive consumers, lower vaccination rates, and execution risks in store closures and cost-saving initiatives.
Last Updated: 10/01/2025, 14:18
Read Full TranscriptEarnings
Latest Release
Apr 03, 2019
EPS / Forecast
-- / 1.76
Revenue / Forecast
-- / 34.59B
People Also Watch
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.